SB 1325 authorizes public school districts, open-enrollment charter schools, and private schools in Texas to contract with private vendors for the supply of medication and equipment to treat respiratory distress. Additionally, the bill allows schools to obtain training services from those vendors for staff and volunteers who may administer the medication in emergency situations. This legislative measure adds a new section—Section 38.2115—to Subchapter E, Chapter 38 of the Texas Education Code, expanding the framework for school-based emergency health response.
The bill is designed to enhance schools’ ability to respond quickly and effectively to respiratory emergencies, such as asthma attacks or anaphylaxis, which can occur during school hours or events. By expressly allowing schools to partner with outside providers, the legislation seeks to ensure that necessary medical resources and training are accessible without requiring school districts to bear the sole burden of developing in-house capabilities. Importantly, the bill does not mandate these contracts—it simply provides the legal authority for schools to pursue them at their discretion.
This flexibility-based approach empowers local educational institutions to decide what level of medical preparedness is appropriate for their students and staff. It supports the development of locally tailored health protocols while maintaining parental trust and community oversight.
The originally filed version of SB 1325 focused on two core changes to the Education Code. First, it amended Section 38.211 to authorize the Texas Department of State Health Services (DSHS)—specifically, the commissioner or the chief medical executive—to issue a statewide standing order for medication used in treating respiratory distress in schools. This expanded the scope of existing law, which previously focused primarily on epinephrine auto-injectors, to include additional medication for respiratory distress. Second, it introduced a new Section 38.2115 allowing schools to contract with vendors for both medication and training.
The Committee Substitute for SB 1325 retains the new Section 38.2115 but removes the proposed amendment to Section 38.211. This means that the final version does not include language authorizing a standing order from the Department of State Health Services for respiratory medication, nor does it amend subsection (c) to extend the legal protections and usage conditions for such medications. Instead, the substitute version solely authorizes school districts, charter schools, and private schools to enter into vendor contracts for obtaining respiratory medications and training.
This shift narrows the bill’s scope, removing state-level public health involvement (via standing orders) and emphasizing local contractual discretion. The revised version is more limited in reach but avoids regulatory complications tied to medical authority and prescriptive oversight. This reflects a legislative pivot away from statewide health infrastructure toward localized, opt-in service options for schools.